Stay updated on Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.

Latest updates to the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a clinical trial involving letetresgene autoleucel (GSK3377794) and the addition of information about a new study design that focuses on GSK3377794 as a treatment option.SummaryDifference21%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
Stay in the know with updates to Lete-cel Immunotherapy Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lete-cel Immunotherapy Combo in NSCLC Clinical Trial page.